1. Home
  2. TDOC vs CTMX Comparison

TDOC vs CTMX Comparison

Compare TDOC & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$5.45

Market Cap

984.7M

Sector

Health Care

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.70

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
CTMX
Founded
2002
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
984.7M
977.1M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
TDOC
CTMX
Price
$5.45
$4.70
Analyst Decision
Buy
Strong Buy
Analyst Count
18
10
Target Price
$7.50
$12.10
AVG Volume (30 Days)
4.4M
10.0M
Earning Date
04-29-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
N/A
EPS
N/A
N/A
Revenue
$2,406,840,000.00
$76,201,000.00
Revenue This Year
$1.27
N/A
Revenue Next Year
$1.25
$27.22
P/E Ratio
N/A
$22.58
Revenue Growth
18.41
N/A
52 Week Low
$4.40
$0.40
52 Week High
$9.77
$8.21

Technical Indicators

Market Signals
Indicator
TDOC
CTMX
Relative Strength Index (RSI) 51.02 48.64
Support Level $4.44 $3.55
Resistance Level $5.49 $6.20
Average True Range (ATR) 0.22 0.61
MACD -0.01 -0.02
Stochastic Oscillator 53.17 15.74

Price Performance

Historical Comparison
TDOC
CTMX

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: